Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
443.16
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
72
73
Next >
2 Biotech Stocks You Can Buy Hand Over Fist This Month
↗
November 08, 2024
Both stocks have made significant breakthroughs.
Via
The Motley Fool
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
↗
November 05, 2024
Via
Benzinga
Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday?
↗
November 05, 2024
Wall Street rallied on Tuesday as improved investor sentiment aligned with millions of Americans casting their votes for the 47th president.
Via
Benzinga
5 Top Stocks to Buy in November
↗
November 05, 2024
From blue chip dividend stocks to industry-leading growth stocks, there are plenty of bargains in today's market if you know where to look.
Via
The Motley Fool
Assessing Vertex Pharmaceuticals: Insights From 11 Financial Analysts
↗
November 05, 2024
Via
Benzinga
Looking Into Vertex Pharmaceuticals's Recent Short Interest
↗
October 21, 2024
Via
Benzinga
Market Whales and Their Recent Bets on VRTX Options
↗
October 18, 2024
Via
Benzinga
My 2 Favorite Growth Stocks to Buy Hand Over Fist in November
↗
November 05, 2024
The sky's the limit for these stocks.
Via
The Motley Fool
Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call Transcript
↗
November 04, 2024
VRTX earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Vertex Pharmaceuticals Beats Third-Quarter Estimates As Pain Treatment Looms
↗
November 04, 2024
Vertex Pharmaceuticals beat third-quarter expectations on Monday. The company also raised its sales outlook.
Via
Investor's Business Daily
Vertex Reports Third Quarter 2024 Financial Results
November 04, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Volatility Hits Large Cap Biopharma: Active Rebalancing May Be Required
↗
November 04, 2024
A bit of earnings and election jitters roiled the market last week reordering the leaderboard in biopharma stocks.
Via
Talk Markets
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
↗
November 04, 2024
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday.
Via
Benzinga
Jim Cramer Says Vertex Doing 'Lord's Work': Can Q3 Earnings Outshine Bearish Charts?
↗
November 04, 2024
VRTX to report Q3 earnings, expected EPS $4.14 and $2.72B in revenue. Cramer calls it a buy, analysts see 22% upside. Stock faces bearish trend.
Via
Benzinga
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers
↗
November 02, 2024
It won't be able to be profitable without hitting its targets for both of these figures.
Via
The Motley Fool
As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report
↗
November 01, 2024
Amid the election, and a Fed rate vote, earnings season roars ahead.
Via
Investor's Business Daily
Topics
Economy
Stocks
Jim Cramer: This Financial Stock Is 'One Of The Most Consistent, Great Companies'
↗
October 31, 2024
Mad Money's Jim Cramer recommends buying T. Rowe Price Group. "I think it's such a great company," he added.
Via
Benzinga
Vertex to Participate in Upcoming November Investor Conferences
October 29, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 5 Years
↗
October 28, 2024
Via
Benzinga
These 10 Stocks Were The Best S&P 500 Performers In 2017 When Trump Was President: Will History Repeat Itself?
↗
October 28, 2024
A look back at the top 10 S&P 500 performing stocks in 2017 under Donald Trump's first year as president and what it could mean for his re-election efforts.
Via
Benzinga
Topics
Government
Stocks
12 High-Growth Stocks That Could Deliver Parabolic Returns
↗
October 28, 2024
These 12 innovative companies could deliver exponential returns over the next quarter century.
Via
The Motley Fool
Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress
October 25, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
The Smartest Growth Stock to Buy With $500 Right Now
↗
October 25, 2024
This stock might not be available for under $500 for long.
Via
The Motley Fool
Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits
↗
October 24, 2024
Its latest report of clinical data suggests it has a winner on its hands.
Via
The Motley Fool
Why We Buy Stocks
↗
October 21, 2024
Is fear of missing out (FOMO) controlling your portfolio?
Via
The Motley Fool
Prediction: These 2 Stocks Will Beat the S&P 500 Through 2030
↗
October 19, 2024
There's no need to change a winning formula.
Via
The Motley Fool
Topics
Stocks
Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting
October 18, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (19 Ratings)
↗
October 17, 2024
Via
Benzinga
Here's How Much $1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today
↗
October 16, 2024
Via
Benzinga
Got $1,000? 2 Magnificent Growth Stocks to Buy and Hold Forever
↗
October 13, 2024
These profitable companies are facing long-term growth runways.
Via
The Motley Fool
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
72
73
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
